Diabetes: J&J loses a round in glucose testing battle with Shasta

November 7, 2013 by Arezu Sarvestani

A Federal Circuit Court rules that Shasta Technologies is within its right to sell glucose testing strips designed to work with Johnson & Johnson's OneTouch blood glucose meters.

Diabetes: J&J loses a round in glucose testing battle with Shasta

Johnson & Johnson (NYSE:JNJ) and its LifeScan subsidiary took a major hit in an ongoing feud with Shasta Technologies when a court ruled this week that Shasta may develop and distribute glucose testing strips that work with LifeScan's OneTouch blood glucose meters.

In a split decision, the panel reversed a lower court's decision and wiped out an injunction preventing Shasta from selling its glucose testing strips. The court warned that preserving LifeScan's test strip injunction would give the company too much monopoly power over the market.

Comments